Funds and ETFs Sopharma AD

Equities

SFA

BG11SOSOBT18

Drug Retailers

End-of-day quote Bulgaria S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
6.04 BGN +1.34% Intraday chart for Sopharma AD 0.00% +5.59%
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.04 BGN
Average target price
7.14 BGN
Spread / Average Target
+18.21%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SFA Stock
  4. Funds and ETFs Sopharma AD